VTAK
Catheter Precision, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Catheter Precision (VTAK) Stock: Buy, Sell, or Hold?
$0.15
0.00 (-0.66%)
▼
5d:
-1.76%
30d:
-24.76%
90d:
-80.29%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (82%)
Quality Score
58/100
Position
FAIR
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$2.00
+1224.5% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$0.13 / $0.16
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: VTAK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When VTAK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VTAK is currently trading at $0.15, which is considered fair based on recent price action.
Technical Outlook: Technically, VTAK is in a strong downtrend. Immediate support is located at $0.13, while resistance sits at $0.16.
Market Sentiment: VTAK scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.00 (+1224.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTAK is in a strong downtrend. Immediate support is located at $0.13, while resistance sits at $0.16.
Market Sentiment: VTAK scores 93/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.00 (+1224.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
58/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
81.6%
Trading Range & Key Levels
Support Level
$0.13
Resistance Level
$0.16
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (93/100)
- BULLISH: Trading 1224.5% below Wall St target ($2.00)
- CAUTION: Bottoming setup, but lagging the sector by 13% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-0.47
Wall Street Target
$2.00
(+1224.5%)
Revenue Growth (YoY)
380.7%
Share VTAK Analysis
Share this live VTAK analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VTAK)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Sep 30, 2026
Daily AI digest
AI Retail Discussion Summary:
There is a single bullish sentiment on StockTwits regarding $VTAK, with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTAK showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 38 SELL |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 38 SELL |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VTAK Research Pages
